Cargando…

P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA

Detalles Bibliográficos
Autores principales: Da Ros, Ambra, Indio, Valentina, Peloso, Alberto, Tregnago, Claudia, Borella, Giulia, Benetton, Maddalena, Longo, Giorgia, Bresolin, Silvia, Buldini, Barbara, Pession, Andrea, Locatelli, Franco, Pigazzi, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429427/
http://dx.doi.org/10.1097/01.HS9.0000968564.08959.22
_version_ 1785090710393847808
author Da Ros, Ambra
Indio, Valentina
Peloso, Alberto
Tregnago, Claudia
Borella, Giulia
Benetton, Maddalena
Longo, Giorgia
Bresolin, Silvia
Buldini, Barbara
Pession, Andrea
Locatelli, Franco
Pigazzi, Martina
author_facet Da Ros, Ambra
Indio, Valentina
Peloso, Alberto
Tregnago, Claudia
Borella, Giulia
Benetton, Maddalena
Longo, Giorgia
Bresolin, Silvia
Buldini, Barbara
Pession, Andrea
Locatelli, Franco
Pigazzi, Martina
author_sort Da Ros, Ambra
collection PubMed
description
format Online
Article
Text
id pubmed-10429427
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104294272023-08-17 P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA Da Ros, Ambra Indio, Valentina Peloso, Alberto Tregnago, Claudia Borella, Giulia Benetton, Maddalena Longo, Giorgia Bresolin, Silvia Buldini, Barbara Pession, Andrea Locatelli, Franco Pigazzi, Martina Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429427/ http://dx.doi.org/10.1097/01.HS9.0000968564.08959.22 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Da Ros, Ambra
Indio, Valentina
Peloso, Alberto
Tregnago, Claudia
Borella, Giulia
Benetton, Maddalena
Longo, Giorgia
Bresolin, Silvia
Buldini, Barbara
Pession, Andrea
Locatelli, Franco
Pigazzi, Martina
P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
title P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
title_full P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
title_fullStr P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
title_full_unstemmed P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
title_short P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA
title_sort p414: patient-derived xenograft models are the leading strategy to identify new agents for pediatric acute myeloid leukemia
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429427/
http://dx.doi.org/10.1097/01.HS9.0000968564.08959.22
work_keys_str_mv AT darosambra p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT indiovalentina p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT pelosoalberto p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT tregnagoclaudia p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT borellagiulia p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT benettonmaddalena p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT longogiorgia p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT bresolinsilvia p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT buldinibarbara p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT pessionandrea p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT locatellifranco p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia
AT pigazzimartina p414patientderivedxenograftmodelsaretheleadingstrategytoidentifynewagentsforpediatricacutemyeloidleukemia